Neumora Therapeutics Inc (NMRA) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Neumora Therapeutics Inc   (NASDAQ: NMRA)


Neumora Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Neumora Therapeutics Inc's ROI in the second quarter of 2026?
Neumora Therapeutics Inc recorded a cumulative net loss of $-213 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -160.01%.

Within the Healthcare sector 700 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 4161, from total ROI ranking in the first quarter of 2026 at 4808.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -48.86 % -47.73 % -47.51 % -45.51 % -42.02 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 97 124 159 152 203
Return On Investment (TTM) -160.01 % -139.65 % -127.61 % -108.5 % -96.96 %
NMRA's Overall Ranking # 4161 # 4808 # 4200 # 4198 # 4184
Seq. Investment Change TTM -16.51 % -14.23 % -14.75 % -16.23 % -14.66 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -213 -222 -237 -236 -252

NMRA Company Profile >> Back to NMRA Roi Comparisons >> See Annual NMRA Return On Investment



Return On Investment NMRA's Ranking
Within: No.
Industry # 117
Sector # 701
Overall # 4161

Return On Investment Statistics
High Average Low
-13.23 %
-76.05 %
-160.01 %
  (Jun 30 2026)







Financial Statements
Neumora Therapeutics Inc's II. Quarter Investments $ 97 Millions NMRA's Balance sheet
Neumora Therapeutics Inc's II. Quarter Income $ -43 Millions Quarterly NMRA's Income Statement
NMRA's Income by Division See NMRA's Income by Division


NMRA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023

Total Investments in Millions 159 287 471 0 0
Y / Y Investment Growth -44.76 % -39.06 % - - -
Net Income in Millions -237 -244 -236 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -149.39 % -84.92 % -50.08 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NMRA's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NMRA's Competitors
Subscribers only: Roi for Neumora Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for NMRA's Customers

Other Ratios
NMRA's Roa NMRA's Inventory Turnover Ratio NMRA's Growth Rates NMRA's Dividend Statistics
NMRA's Profitability Ratios NMRA's Asset Turnover Ratio NMRA's Dividend Growth
NMRA's Roe NMRA's Valuation Ratios NMRA's Financial Strength Ratios NMRA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:42:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.